Proton Pump Inhibitors MDL

Posted by Sarah Showard | Aug 03, 2017 | 0 Comments

Proton Pump Inhibitors (PPI) have officially been centralized in the District of New Jersey by the Judicial Panel on Multi-District Litigation (JPML) on the evening of August 2nd, 2017. More than (60) cases of the (161) constituent actions are already pending in the District of New Jersey. Judge Claire C. Cecchi will oversee Proton Pump Inhibitors MDL-2789.  This was the plaintiff's second motion to centralize after a denied request took place in January of 2017. The JPML reserves the right to grant additional motions to centralize under significant circumstances and that's exactly what they determined from a recent federal hearing in Los Angeles on August 3rd, 2017.

One of the key differences with this motion to centralize was having support from (2) of the primary defendants; AstraZeneca and Pfizer. Meanwhile, Proctor and Gamble "do not oppose centralization" while both Takeda and Novartis opposed centralization. It should be noted the panel opposed Takeda's request to be carved out of the MDL, considering there are a large number of "mixed use" cases filed with the potential to increase significantly.

Another point of contention is the fact each of these defendants are competitors and there are concerns over the protection of trade secrets, etc. The JPML addressed this concern by stating, "The transferee judge has wide discretion as to how the MDL should be defined". They continue to express the transferee judge may establish separate discovery, motion tracks and manage pretrial proceedings efficiently. This could be a non-issue as most of these medications no longer have patent protection.

For more information, including case acquisition, please call (480) 970-1180 to speak with a representative of Velawcity.

About the Author

Sarah Showard

Sarah Showard graduated from the University of Maryland in 1985, Magna Cum Laude with a Bachelor of Arts in English-Linguistics and a Certification in Womens Studies. She then graduated from New York University School of Law in 1988. Sarah began practice initially as an insurance defense attorne...


There are no comments for this post. Be the first and Add your Comment below.

Leave a Comment

Showard Law Firm-Tucson's Local Law Firm for defective drug & medical device claims.

Showard 20staff 202017 201026 20special 20edit edit.jpg 20small

Showard Law Firm is dedicated to compassionate representation for our clients who have been injured by defective products, dangerous drugs or the negligence of any individual or company. We are experienced in litigation and ready to ensure you receive the maximum possible settlement for your injuries, medical bills, mental anguish and other losses.

Sarah Showard and Dr. Peter Ott - 2018 Heart Ball Chairs


Sarah and Peter are the proud chairs of this year's Heart and Stroke Ball, held on 2/17/18 at the El Conquistador. With a western theme "Heart of the West", this important fund raiser is in its 60th year, all raising funds to help with research and advances in the case against heart disease in the Tucson community.